These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 9257240)
1. Quantitative measurement of HCV RNA in the serum: a comparison of three assays based on different principles. Ichijo T; Matsumoto A; Kobayashi M; Furihata K; Tanaka E J Gastroenterol Hepatol; 1997 Jul; 12(7):500-6. PubMed ID: 9257240 [TBL] [Abstract][Full Text] [Related]
2. Comparison of HCV RNA assays for the detection and quantification of hepatitis C virus RNA levels in serum of patients with chronic hepatitis C treated with interferon. Trabaud MA; Bailly F; Si-Ahmed SN; Chevallier P; Sepetjan M; Colucci G; Trépo C J Med Virol; 1997 May; 52(1):105-12. PubMed ID: 9131466 [TBL] [Abstract][Full Text] [Related]
3. Comparison of serum hepatitis C virus RNA concentration by branched DNA probe assay with competitive reverse transcription polymerase chain reaction as a predictor of response to interferon-alpha therapy in chronic hepatitis C patients. Toyoda H; Nakano S; Kumada T; Takeda I; Sugiyama K; Osada T; Kiriyama S; Orito E; Mizokami M J Med Virol; 1996 Apr; 48(4):354-9. PubMed ID: 8699168 [TBL] [Abstract][Full Text] [Related]
4. Clinical application of the Quantiplex HCV RNA 2.0 and Amplicor HCV Monitor assays for quantifying serum hepatitis C virus RNA. Yu ML; Chuang WL; Chen SC; Lin ZY; Hsieh MY; Wang LY; Chang WY J Clin Pathol; 1999 Nov; 52(11):807-11. PubMed ID: 10690168 [TBL] [Abstract][Full Text] [Related]
5. Quantitative measurement of serum HCV RNA in patients with chronic hepatitis C: comparison between Amplicor HCV monitor system and branched DNA signal amplification assay. Lu RH; Hwang SJ; Chan CY; Chang FY; Lee SD J Clin Lab Anal; 1998; 12(2):121-5. PubMed ID: 9524297 [TBL] [Abstract][Full Text] [Related]
6. Comparison of quantitative cDNA-PCR with the branched DNA hybridization assay for monitoring plasma hepatitis C virus RNA levels in haemophilia patients participating in a controlled interferon trial. Bresters D; Cuypers HT; Reesink HW; Mauser-Bunschoten EP; van den Berg HM; Schaasberg WP; Wilber JC; Urdea MS; Neuwald P; Lelie PN J Med Virol; 1994 Jul; 43(3):262-8. PubMed ID: 7931188 [TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of the automated COBAS AMPLICOR HCV MONITOR test version 2.0 for quantifying serum hepatitis C virus RNA and comparison to the quantiplex HCV version 2.0 test. Yu ML; Chuang WL; Dai CY; Chen SC; Lin ZY; Hsieh MY; Wang LY; Chang WY J Clin Microbiol; 2000 Aug; 38(8):2933-9. PubMed ID: 10921954 [TBL] [Abstract][Full Text] [Related]
8. Usefulness of simple assays for serum concentration of hepatitis C virus RNA and HCV genotype in predicting the response of patients with chronic hepatitis C to interferon alpha 2a therapy. Suzuki T; Tanaka E; Matsumoto A; Urushihara A; Sodeyama T J Med Virol; 1995 Jun; 46(2):162-8. PubMed ID: 7636506 [TBL] [Abstract][Full Text] [Related]
9. Usefulness of HCV-RNA assays in efficacy evaluation of interferon treatment for chronic hepatitis C: Amplicor HCV assay and branched DNA probe assay. Nomura H; Kimura Y; Rikimaru N; Tada H; Okamoto O; Shiraishi G; Kashiwagi S J Infect; 1997 May; 34(3):249-55. PubMed ID: 9200033 [TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of hepatitis C virus RNA quantitation by branched DNA, NASBA, and monitor assays. Lunel F; Cresta P; Vitour D; Payan C; Dumont B; Frangeul L; Reboul D; Brault C; Piette JC; Huraux JM Hepatology; 1999 Feb; 29(2):528-35. PubMed ID: 9918931 [TBL] [Abstract][Full Text] [Related]
11. Assessment of hepatitis C viremia using molecular amplification technologies: correlations and clinical implications. Gretch DR; dela Rosa C; Carithers RL; Willson RA; Williams B; Corey L Ann Intern Med; 1995 Sep; 123(5):321-9. PubMed ID: 7542853 [TBL] [Abstract][Full Text] [Related]
12. Quantitative assessment of hepatitis C virus RNA by polymerase chain reaction and a digoxigenin detection system: comparison with branched DNA assay. Yeh CT; Shyu WC; Sheen IS; Chu CM; Liaw YF J Virol Methods; 1997 May; 65(2):219-26. PubMed ID: 9186945 [TBL] [Abstract][Full Text] [Related]
13. Preclinical evaluation of AMPLICOR hepatitis C virus test for detection of hepatitis C virus RNA. Nolte FS; Thurmond C; Fried MW J Clin Microbiol; 1995 Jul; 33(7):1775-8. PubMed ID: 7665645 [TBL] [Abstract][Full Text] [Related]
14. Quantification of hepatitis C virus RNA by RT-PCR in comparison to the branched DNA method. Roth WK; Lee JH; Rüster B; Zeuzem S Z Gastroenterol; 1998 Jan; 36(1):5-11. PubMed ID: 9531684 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the clinical usefulness of COBAS AMPLICOR HCV MONITOR assay (ver2.0): Comparison with AMPLICOR HCV MONITOR assay (ver1.0) and HCV core protein level. Kawai S; Yokosuka O; Imazeki F; Saisho H; Mizuno C J Med Virol; 2002 Nov; 68(3):343-51. PubMed ID: 12226820 [TBL] [Abstract][Full Text] [Related]
16. Quantitative assays for hepatitis C virus in serum as predictors of the long-term response to interferon. Shiratori Y; Kato N; Yokosuka O; Hashimoto E; Hayashi N; Nakamura A; Asada M; Kuroda H; Ohkubo H; Arakawa Y; Iwama A; Omata M J Hepatol; 1997 Sep; 27(3):437-44. PubMed ID: 9314119 [TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of the VERSANT HCV RNA 3.0, QUANTIPLEX HCV RNA 2.0, and COBAS AMPLICOR HCV MONITOR version 2.0 Assays for quantification of hepatitis C virus RNA in serum. Germer JJ; Heimgartner PJ; Ilstrup DM; Harmsen WS; Jenkins GD; Patel R J Clin Microbiol; 2002 Feb; 40(2):495-500. PubMed ID: 11825962 [TBL] [Abstract][Full Text] [Related]
18. Predictive value of different hepatitis C serological assays in the treatment of chronic hepatitis C with interferon alpha. Kobayashi M; Chayama K; Arase Y; Tsubota A; Saitoh S; Suzuki Y; Kobayashi M; Kobayashi M; Ikeda K; Matsuda M; Koike H; Hashimoto M; Kumada H J Gastroenterol; 1999 Feb; 34(1):94-9. PubMed ID: 10204617 [TBL] [Abstract][Full Text] [Related]
19. A comparison of reverse transcription-polymerase chain reaction and branched-chain DNA assays for hepatitis C virus RNA in patients receiving interferon treatment. Consensus Interferon Study Group. Pockros PJ; Bain VG; Hunter EB; Conrad A; Balart A; Hollinger FB; Albert D J Viral Hepat; 1999 Mar; 6(2):145-50. PubMed ID: 10607226 [TBL] [Abstract][Full Text] [Related]
20. Quantification of hepatitis C virus RNA in serum by branched DNA-based signal amplification assays. Pawlotsky JM; Martinot-Peignoux M; Poveda JD; Bastie A; Le Breton V; Darthuy F; Rémiré J; Erlinger S; Dhumeaux D; Marcellin P J Virol Methods; 1999 May; 79(2):227-35. PubMed ID: 10381092 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]